Product Information
Name:Infigratinib mesylate
Brand:Targetmol
Description:Infigratinib (BGJ398), approved in 2021, is an oral pan FGFR inhibitor targeting FGFR-related cholangiocarcinoma.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:656.58
Formula:C27H35Cl2N7O6S
Color/Form:Solid
Technical inquiry about: Infigratinib mesylate
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.